0001104659-22-122151.txt : 20221125 0001104659-22-122151.hdr.sgml : 20221125 20221125181350 ACCESSION NUMBER: 0001104659-22-122151 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221123 FILED AS OF DATE: 20221125 DATE AS OF CHANGE: 20221125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dye Justin CENTRAL INDEX KEY: 0001654539 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55450 FILM NUMBER: 221420917 MAIL ADDRESS: STREET 1: C/O MEDICINE MAN TECHNOLOGIES, INC. STREET 2: 4880 HAVANA STREET, SUITE 201 CITY: DENVER STATE: CO ZIP: 80239 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medicine Man Technologies, Inc. CENTRAL INDEX KEY: 0001622879 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 465289499 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4880 HAVANA STREET STREET 2: SUITE 201 SOUTH CITY: DENVER STATE: CO ZIP: 80239 BUSINESS PHONE: 303-371-0387 MAIL ADDRESS: STREET 1: 4880 HAVANA STREET STREET 2: SUITE 201 SOUTH CITY: DENVER STATE: CO ZIP: 80239 4 1 tm2230784-3_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-11-23 0 0001622879 Medicine Man Technologies, Inc. SHWZ 0001654539 Dye Justin C/O MEDICINE MAN TECHNOLOGIES, INC. 4880 HAVANA ST., STE. 201 DENVER CO 80239 1 1 1 0 CEO Common Stock 2022-11-23 4 A 0 509700 2.00 A 1368062 D Common Stock 9287500 I See footnote The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.79 to $2.10 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Represents shares of common stock held by Dye Capital & Company, LLC ("Dye Capital"). As the general partner of Dye Capital, Mr. Dye has voting and investment control over the securities held by Dye Capital. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. /s/ Daniel R. Pabon, Attorney-in-Fact for Justin Dye 2022-11-25